Multiple myeloma and plasma cell disorders

Siyang Leng, Ajai Chari

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


Plasma cell disorders encompass a number of diagnostic entities, with the most common being multiple myeloma. These disorders typically affect multiple organ systems, and patients can present with a spectrum of symptoms. Evaluation of these disorders requires a comprehensive set of laboratory and radiographic tests. Common to these disorders is the finding of a monoclonal protein in the serum, or monoclonal plasma cells on biopsy. Risk stratification of these disorders is important for determining prognosis and treatment. Treatment involves chemotherapy, steroids, and sometimes additional modalities such as stem cell transplant, radiotherapy, or surgery. While these disorders generally remain incurable, both therapy and prognosis have significantly improved with the introduction of immunomodulatory agents and proteasome inhibitors, and will likely continue to improve with the advent of immunotherapies and other targeted agents.

Original languageEnglish
Title of host publicationOncology
Number of pages10
ISBN (Electronic)9781119189596
ISBN (Print)9781119189558
StatePublished - 30 Aug 2019


  • Amyloidosis
  • MGUS
  • MM
  • Multiple myeloma
  • Plasma cells
  • Smoldering
  • Waldenström macroglobulinemia


Dive into the research topics of 'Multiple myeloma and plasma cell disorders'. Together they form a unique fingerprint.

Cite this